Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
PaperCitations, authors & open-access status
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 46 citations, 2019 year and closed oa status.
46
Citations
2019
Year
closed
OA Status